Literature DB >> 29244798

Amplitude-integrated electroencephalography during the first 72 h after birth in neonates diagnosed prenatally with congenital heart disease.

Mirthe J Mebius1, Nathalie J E Oostdijk1, Sara J Kuik1, Arend F Bos1, Rolf M F Berger2, Caterina M Bilardo3, Elisabeth M W Kooi1, Hendrik J Ter Horst1.   

Abstract

BackgroundLittle is known on amplitude-integrated electroencephalography (aEEG) during the first few days after birth in neonates with congenital heart disease (CHD). Our aim was, therefore, to assess electrocortical activity using aEEG within the first 72 h after birth in neonates diagnosed prenatally with CHD, and to define independent prenatal and postnatal predictors for abnormal aEEG.MethodsNeonates with CHD who were admitted to the neonatal intensive care unit between 2010 and 2017 were retrospectively included. We assessed aEEG background patterns, sleep-wake cycling, and epileptic activity during the first 72 h after birth and defined prenatal and postnatal clinical parameters associated with aEEG patterns.ResultsSeventy-two neonates were included. Twenty-six (36%) had mildly abnormal and six (8%) had severely abnormal aEEG background patterns at some point during the study period. Sleep-wake cycling was present in 97% of the neonates. Subclinical seizures were common (15%), whereas none of the neonates had clinical seizures. Only treatment with sedatives was a significant predictor for abnormal aEEG background patterns, explaining 56% of the variance.ConclusionAbnormal aEEG background patterns are common and are strongly associated with treatment with sedatives in neonates with prenatally diagnosed CHD. Future studies should assess the association between early postnatal aEEG abnormalities and neurodevelopmental outcome.

Entities:  

Mesh:

Year:  2018        PMID: 29244798     DOI: 10.1038/pr.2017.311

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  30 in total

1.  Effect of sedation and analgesia on postoperative amplitude-integrated EEG in newborn cardiac patients.

Authors:  Vera Bernet; Beatrice Latal; Giancarlo Natalucci; Carsten Doell; Anna Ziegler; Gabriele Wohlrab
Journal:  Pediatr Res       Date:  2010-06       Impact factor: 3.756

2.  Effects of morphine and midazolam on sleep-wake cycling in amplitude-integrated electroencephalography in post-surgical neonates ≥ 32 weeks of gestational age.

Authors:  Monika Olischar; Andrew J Davidson; Katherine J Lee; Rod W Hunt
Journal:  Neonatology       Date:  2012-01-27       Impact factor: 4.035

Review 3.  Amplitude integrated electroencephalography in the full-term newborn.

Authors:  Linda S de Vries; Mona C Toet
Journal:  Clin Perinatol       Date:  2006-09       Impact factor: 3.430

4.  Amplitude integrated electroencephalographic activity in infants with congenital heart disease before surgery.

Authors:  H J ter Horst; M Mud; M T R Roofthooft; A F Bos
Journal:  Early Hum Dev       Date:  2010-12       Impact factor: 2.079

5.  Evidence of second-trimester changes in head biometry and brain perfusion in fetuses with congenital heart disease.

Authors:  N Masoller; J M Martínez; O Gómez; M Bennasar; F Crispi; M Sanz-Cortés; G Egaña-Ugrinovic; J Bartrons; B Puerto; E Gratacós
Journal:  Ultrasound Obstet Gynecol       Date:  2014-07-08       Impact factor: 7.299

6.  Association between electroencephalographic findings and neurologic status in infants with congenital heart defects.

Authors:  C Limperopoulos; A Majnemer; B Rosenblatt; M I Shevell; C Rohlicek; C Tchervenkov; R Gottesman
Journal:  J Child Neurol       Date:  2001-07       Impact factor: 1.987

7.  Severity of Fetal Brain Abnormalities in Congenital Heart Disease in Relation to the Main Expected Pattern of in utero Brain Blood Supply.

Authors:  Narcís Masoller; Magda Sanz-Cortés; Fàtima Crispi; Olga Gómez; Mar Bennasar; Gabriela Egaña-Ugrinovic; Núria Bargalló; Josep María Martínez; Eduard Gratacós
Journal:  Fetal Diagn Ther       Date:  2015-11-28       Impact factor: 2.587

8.  Postoperative Amplitude-Integrated Electroencephalography Predicts Four-Year Neurodevelopmental Outcome in Children with Complex Congenital Heart Disease.

Authors:  Beatrice Latal; Gabriele Wohlrab; Barbara Brotschi; Ingrid Beck; Walter Knirsch; Vera Bernet
Journal:  J Pediatr       Date:  2016-07-22       Impact factor: 4.406

9.  Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures.

Authors:  D M Murray; G B Boylan; I Ali; C A Ryan; B P Murphy; S Connolly
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-07-11       Impact factor: 5.747

10.  Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery.

Authors:  Maryam Y Naim; J William Gaynor; Jodi Chen; Susan C Nicolson; Stephanie Fuller; Thomas L Spray; Dennis J Dlugos; Robert R Clancy; Livia Vianez Costa; Daniel J Licht; Rui Xiao; Heather Meldrum; Nicholas S Abend
Journal:  J Thorac Cardiovasc Surg       Date:  2015-04-01       Impact factor: 5.209

View more
  3 in total

Review 1.  Recent advances in our understanding of neurodevelopmental outcomes in congenital heart disease.

Authors:  Brian R White; Lindsay S Rogers; Matthew P Kirschen
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

Review 2.  The Congenital Heart Disease Brain: Prenatal Considerations for Perioperative Neurocritical Care.

Authors:  Cynthia M Ortinau; Joshua S Shimony
Journal:  Pediatr Neurol       Date:  2020-01-22       Impact factor: 3.372

3.  CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial.

Authors:  Raymond Stegeman; Maaike Nijman; Nicolaas J G Jansen; Manon J N L Benders; Johannes M P J Breur; Floris Groenendaal; Felix Haas; Jan B Derks; Joppe Nijman; Ingrid M van Beynum; Yannick J H J Taverne; Ad J J C Bogers; Willem A Helbing; Willem P de Boode; Arend F Bos; Rolf M F Berger; Ryan E Accord; Kit C B Roes; G Ardine de Wit
Journal:  Trials       Date:  2022-02-23       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.